IceCure Medical Ltd. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
IceCure Medical Ltd. (ICCM) had Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $1.37 per share as of 2023-02-19, per its 20-F filed 2026-03-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-03-17
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 0 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 1 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2023-02-19 | $1.37 20-F · filed 2026-03-17 | |||
| 2022-12-31 | $3.30 20-F · filed 2023-03-29 | |||
| 2022-07-04 | $1.78 20-F · filed 2025-03-27 | $1.78 20-F · filed 2024-04-03 | ||
| 2022-03-23 | $2.73 20-F · filed 2025-03-27 | $2.73 20-F · filed 2024-04-03 | ||
| 2022-01-12 | $3.61 20-F · filed 2025-03-27 | $3.61 20-F · filed 2024-04-03 | ||
| 2021-12-31 | $2.02 20-F · filed 2023-03-29 | |||
| 2021-04-28 | $5.76 20-F · filed 2024-04-03 | |||
| 2020-12-31 | $1.60 20-F · filed 2023-03-29 | |||
| 2019-12-31 | $1.76 20-F/A · filed 2022-08-22 |